Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
New epilepsy therapies in development
2024 Standout
Immune determinants of the pre-metastatic niche
2023 Standout
Works of Michalis Michael being referenced
Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer
2010
Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Michalis Michael | 227 | 167 | 222 | 19 | 478 | |
| Merry Tetef | 255 | 81 | 146 | 28 | 559 | |
| Y Mogi | 90 | 128 | 184 | 28 | 447 | |
| Jolanta Libura | 236 | 150 | 195 | 13 | 570 | |
| Hidenori Kasahara | 128 | 54 | 195 | 21 | 449 | |
| Yuichi Konuma | 137 | 176 | 181 | 16 | 478 | |
| Risu Na | 218 | 41 | 176 | 25 | 442 | |
| Qizhe Cai | 131 | 195 | 228 | 30 | 527 | |
| Shande Tang | 150 | 163 | 134 | 15 | 442 | |
| Nishant Tageja | 163 | 206 | 182 | 33 | 502 | |
| Hideyuki Yasuno | 162 | 165 | 131 | 15 | 484 |
All Works
Login with ORCID to disown or claim papers
Loading papers...